Pancreatic Cancer Research

ResearcherRadboud University Medical CenterActive in the last 2 years

Jai Prakash

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1050-650X; OpenAlex author ID A5100756942. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
33
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 4 papers

Papers 13

  1. Engineered cyclic peptide targeting ITGA5 disrupts tumor-stroma interaction to overcome desmoplasia and resistance in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.apsb.2025.10.022↗
  2. Precision targeting of stromal states in pancreatic cancer: a clinical perspective. Last author DOI 10.1016/j.trecan.2026.07.003↗
  3. FGFR Inhibitor AZD4547 Disrupts Inflammatory CAF Crosstalk With Cancer Cells and Macrophages and Attenuates Metastasis in Pancreatic Cancer. Last author DOI 10.1096/fj.202504573rr↗
  4. Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in pancreatic ductal adenocarcinoma Co-author DOI 10.21203/rs.3.rs-6606556/v1↗
  5. Biomimetic Tumour Model Systems for Pancreatic Ductal Adenocarcinoma in Relation to Photodynamic Therapy. Co-author DOI 10.3390/ijms26136388↗
  6. Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer. First author DOI 10.2147/ijn.s279192↗
  7. Novel 3D µtissues Mimicking the Fibrotic Stroma in Pancreatic Cancer to Study Cellular Interactions and Stroma-Modulating Therapeutics. Last author DOI 10.3390/cancers13195006↗
  8. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer. Last author DOI 10.1096/fj.201802336r↗
  9. ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer. Last author DOI 10.1126/sciadv.aax2770↗
  10. Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer. Last author DOI 10.1016/j.canlet.2018.01.072↗
  11. Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo. Last author DOI 10.1016/j.jconrel.2018.09.031↗
  12. Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. Co-author DOI 10.1038/bjc.2017.140↗
  13. SIRT1 inhibition in pancreatic cancer models: contrasting effects in vitro and in vivo. Last author DOI 10.1016/j.ejphar.2015.03.064↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Praneeth Reddy Kuninty · 5 shared papers, 2017–2026 · strength 0.83
  2. Ahmed M. R. H. Mostafa · 2 shared papers, 2026 · strength 0.72
  3. Deby Fajar Mardhian · 4 shared papers, 2018–2026 · strength 0.61
  4. Maarten F. Bijlsma · 2 shared papers, 2019–2026 · strength 0.58
  5. Anna Wolters · 1 shared paper, 2026 · strength 0.50
  6. Kunal P. Pednekar · 2 shared papers, 2021–2026 · strength 0.49
  7. Jonas Schnittert · 4 shared papers, 2017–2019 · strength 0.36
  8. Arne Östman · 4 shared papers, 2015–2019 · strength 0.32
  9. Jennifer P. Morton · 1 shared paper, 2026 · strength 0.30
  10. Miles Aaron Miller · 1 shared paper, 2026 · strength 0.29
  11. David Lagares · 1 shared paper, 2026 · strength 0.29
  12. Tao Lu · 1 shared paper, 2021 · strength 0.28
  13. Yazan S. Khaled · 1 shared paper, 2025 · strength 0.24
  14. Olivia Prankerd Smith · 1 shared paper, 2025 · strength 0.24
  15. David George Jayne · 1 shared paper, 2025 · strength 0.24
  16. Andrew Malvern Smith · 1 shared paper, 2025 · strength 0.24
  17. Nicole Lintern · 1 shared paper, 2025 · strength 0.24
  18. Sabrina Oliveira · 1 shared paper, 2025 · strength 0.24
  19. Carina Strell · 2 shared papers, 2015–2017 · strength 0.12
  20. Susanna W.L. de Geus · 1 shared paper, 2019 · strength 0.08
  21. Peter J.K. Kuppen · 1 shared paper, 2019 · strength 0.08
  22. Cornelis F.M. Sier · 1 shared paper, 2019 · strength 0.08
  23. Hanneke W.M. van Laarhoven · 1 shared paper, 2019 · strength 0.08
  24. Alexander L. Vahrmeijer · 1 shared paper, 2019 · strength 0.08
  25. Chern Ein Oon · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.